According to the company, the Atlas II implantable cardioverter defibrillator (ICD) is a device that significantly enhances telemetry speed for faster communications – up to five times faster than predecessor devices – which results in quicker, more convenient follow-up visits for patients and physicians.
William Phillips, president of St Jude Medical Japan, said: “The Atlas II devices offer important clinical benefits due to their high-energy capability, advanced diagnostics and increased telemetry speed. Customized options give physicians more control and help simplify patient management through better detection, diagnosis and delivery of tailored therapy.”